It is therefore possible that CYP1B1 contributes to tumor progression through similar mechanisms as CYP3A5 by producing terminal HETE products that act as autocrine signaling molecules by activating the 20-HETE/GPR75 signaling cascades previously mentioned. Here, CYP1B1 is linked to neoplasm.